Margin dodolan resik: Qilian International Holding (QLI)

Tandha merek Qilian International Holding Group Limited (QLI)

The net margin percentage demonstrates the efficiency of delegating raw material procurement to cooperatives, which minimizes supply risks for Qilian International (QLI). The business relies on government licensing and certified laboratories, creating a high barrier to entry. The -16.70 metric indicates the status of a company whose growth is constrained by strict PRC controls and a dependence on administrative resources within the traditional medicine sector.

Rentabilitas dodolan resik qlsyy.net (QLI): kanggo periode 04.07.2022 - 17.08.2024

Ringkesan rincian data analitis Qilian International Corp (QLI)

Ringkesan analisis perusahaan:Qilian International, QLI
Barang unggulan Qilian International Holding Group Limited

Net profit margin measures the portion of profit remaining after deducting all operating and non-operating expenses from revenue. For Qilian International (QLI), this metric reflects the efficiency of implementing robotic extraction lines for licorice raw materials. By analyzing the profit margin ratio, an investor can determine whether AI control systems are reducing costs. A divergence between revenue and profit growth rates signals inefficiency in capital expenditures, while a stable trend confirms the qualitative scaling of the business.

Analisis pesaing Qilian International

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan resik amneal.com (AMRX)|Margin dodolan resik PRGO (perrigo.com)|Alvotech SA (ALVO) - Margin resik|Liquidia Inc. - Margin dodolan resik|Tingkat bathi miturut bathi resik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Margin resik|Rentabilitas dodolan resik MNKD|Margin resik Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Margin dodolan perusahaan|Margin dodolan resik SPRY|TBPH - Margin resik|Aquestive Pharma - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik scpharmaceuticals.com SCPH|Tectonic - Margin dodolan resik|TNXP - Margin dodolan resik|SXTC: Margin dodolan resik|Eupraxia Pharma - Tingkat bathi resik|BHST (bioharvest.com) - Margin dodolan resik|Rentabilitas dodolan resik EXOZ (invizyne.com)|Margin dodolan resik ORMP|Margin dodolan perusahaan Entera Bio|Margin dodolan resik HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Margin resik|Cumberland Corp - Margin dodolan resik|QNTM - Margin dodolan resik|FibroGen, Inc. (FGEN) - Margin resik|TELO: Rentabilitas resik perusahaan|RANI (Rani Therapeutics Inc) - Margin dodolan resik|Margin resik synergychc.com SNYR|Margin resik Rallybio Corp. (RLYB)|LEXX - Margin resik|Margin dodolan resik PULM (pulmatrix.com)|Rentabilitas resik perusahaan PTHL (Pheton)|APM - Margin resik|Margin dodolan perusahaan Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Margin resik|TNF Pharma (TNFA) - Margin dodolan resik|YCBD (cbdmd.com) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik PainReform (PRFX)|Margin resik Altamira Therapeutics (CYTO)|Margin dodolan perusahaan Lipella Pharma|Optinose - Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan pieris.com (PIRS)|PROC - Margin resik|Margin bathi resik PTPI|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma